We conducted a population‐based cohort study to evaluate the complementary value of
HPV testing to Papanicolaou (Pap) smear and the prevalence and genotype distribution of …

Since infection with oncogenic human papillomavirus (HPV) has been considered a
necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as …

Objective To evaluate new techniques in primary cervical cancer screening programmes.
Design Cross sectional pilot study. Setting Department of Obstetrics and Gynaecology …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

OBJECTIVE: To characterize the cervical cancers diagnosed following a Pap-negative, high
risk human papillomavirus (HPV)-positive (Pap−/HPV+) screen in routine clinical practice …

OBJECTIVE: To compare the performance of human papillomavirus (HPV) DNA detection
against routine Papanicolaou smear for the detection of low-and high-grade cervical …

Although cytology‐based screening programs have significantly reduced mortality and
morbidity from cervical cancer, the global consensus is that primary human papillomavirus …

Objective To present the results of the first 2 years of a human papillomavirus (HPV) test‐
based screening programme outside the research context. Design Population‐based cohort …

Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …

Background Cervical cancer is the major cause of morbidity and mortality in Thai women.
Nevertheless, the preventive strategy such as HPV vaccination program has not been …